EPAS1 and neoplasm: However, the variant allele frequency measured in the patient samples, which demonstrates that surrounding normal tissue has a much lower variant allele frequency than tumor vessels, suggests that there may be a cell- or tissue-specific process that selects for or against proliferation of cells with the EPAS1 gain-of-function mutation.